PM360

SEPTEMBER 28, 2022

For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.

Physicians 109

Physicians Pharma Education Pharma reps 109

Eversana Intouch

JANUARY 11, 2022

Welcome to 2022! Medical science liaisons and medical affairs personnel are becoming increasingly important customer-facing components of the team, as sales rep access continues to be limited. We’re seeing brands increase budgets for Medical Affairs,” says Stewart Young, SVP, Strategic Planning, Intouch Proto.

Marketing 52

Marketing Pharma Medical science Media 52

PM360

SEPTEMBER 15, 2022

More than ever, physician time is at a premium. Heavy patient loads, paperwork, research, presentations at medical meetings, and department/academic obligations make it tough to keep up with the literature, new therapies, and understanding of how community level and peers manage their patients.

Education 52

Education Media Medical Physicians 52

PM360

NOVEMBER 29, 2022

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. They are no longer “just” educating and informing doctors but helping to accelerate medical science innovation. See resource here.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Impetus Digital

APRIL 24, 2023

Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This offers new opportunities to engage with stakeholders beyond just physicians. Digital Transformation in Medical Affairs Sparked by the Pandemic Likewise, Furtner et al.

Medical 52

Medical Education Physicians Healthcare 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Furthermore, an abstract (3588) accepted to the American Society for Haematology (ASH) 2022 meeting due to take place on 10–13 December shows that only 29% of patients with MM who were listed to receive chimeric antigen receptor T-cell (CAR-T) therapies received them within 12 months.

Manufacturing 59

Manufacturing Food and Drug Administration Medical science Patients 59

Medgadget

MARCH 2, 2023

In 2022 the company went public on the NASDAQ and raised about $100 million more. To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources.

Manufacturing 83

Manufacturing Leads Patients Medicine 83